Khan Najat
SEC insider (Form 3/4/5 filer). CIK 0002020969. CEO and President at RECURSION PHARMACEUTICALS, INC. (RXRX). 18 reported Form 4/5 transactions since Sep 2024; latest on Sep 8, 2026. Located in SALT LAKE CITY, UT.
Companies Khan Najat has filed insider reports for
- RECURSION PHARMACEUTICALS, INC. (RXRX): Director, Officer, CEO and President
Khan Najat
CIK: 0002020969
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
RECURSION PHARMACEUTICALS, INC.
Discretionary Trading P&L
Holdings
Transaction History (18 total)
- Sep 8, 2026RXRX
RECURSION PHARMACEUTICALS, INC.
SaleDirect22.4K shares at avg. $3.52$79K - Aug 17, 2026RXRX
RECURSION PHARMACEUTICALS, INC.
Tax PaymentDirect80.5K shares at avg. $3.16$254K - Jun 5, 2026RXRX
RECURSION PHARMACEUTICALS, INC.
SaleDirect23.6K shares at avg. $3.58$84K - May 15, 2026RXRX
RECURSION PHARMACEUTICALS, INC.
Tax PaymentDirect62.7K shares at avg. $3.04$191K - Mar 9, 2026RXRX
RECURSION PHARMACEUTICALS, INC.
SaleDirect28.3K shares at avg. $3.35$95K - Feb 17, 2026RXRX
RECURSION PHARMACEUTICALS, INC.
Tax PaymentDirect14.3K shares at avg. $3.49$50K - Feb 6, 2026RXRX
RECURSION PHARMACEUTICALS, INC.
AwardDirect1.7M shares- - Feb 6, 2026RXRX
RECURSION PHARMACEUTICALS, INC.
AwardDirect30.3K shares- - Feb 6, 2026RXRX
RECURSION PHARMACEUTICALS, INC.
Tax PaymentDirect10.4K shares at avg. $3.98$41K - Dec 22, 2025RXRX
RECURSION PHARMACEUTICALS, INC.
SaleDirect124.4K shares at avg. $4.41$549K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 8, 2026 | RXRX RECURSION PHARMACEUTICALS, INC. | Sale | 22,408 | $3.52 | $78,822 | Direct |
| Aug 17, 2026 | RXRX RECURSION PHARMACEUTICALS, INC. | Tax Payment | 80,498 | $3.16 | $254,374 | Direct |
| Jun 5, 2026 | RXRX RECURSION PHARMACEUTICALS, INC. | Sale | 23,588 | $3.58 | $84,459 | Direct |
| May 15, 2026 | RXRX RECURSION PHARMACEUTICALS, INC. | Tax Payment | 62,701 | $3.04 | $190,611 | Direct |
| Mar 9, 2026 | RXRX RECURSION PHARMACEUTICALS, INC. | Sale | 28,298 | $3.35 | $94,660 | Direct |
| Feb 17, 2026 | RXRX RECURSION PHARMACEUTICALS, INC. | Tax Payment | 14,280 | $3.49 | $49,837 | Direct |
| Feb 6, 2026 | RXRX RECURSION PHARMACEUTICALS, INC. | Award | 1,673,546 | - | $0 | Direct |
| Feb 6, 2026 | RXRX RECURSION PHARMACEUTICALS, INC. | Award | 30,346 | - | $0 | Direct |
| Feb 6, 2026 | RXRX RECURSION PHARMACEUTICALS, INC. | Tax Payment | 10,364 | $3.98 | $41,249 | Direct |
| Dec 22, 2025 | RXRX RECURSION PHARMACEUTICALS, INC. | Sale | 124,403 | $4.41 | $548,592 | Direct |
1-10 of 18 transactions